Daewoong first-quarter sales increase 12%
Published: 2006-07-26 06:57:00
Updated: 2006-07-26 06:57:00
Daewoong Pharm said its first-quarter (April-June) sales rose a better-than-expected 12.4 percent from a year ago, driven by robust sales of flagship products such as Ursa and Almetec (almesartan medoxomil), analysts say.
Sales rose 12.4 percent to 90.2 billion won in the April-June period.
...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
